M&A Deal Summary |
|
|---|---|
| Date | 2021-05-13 |
| Target | TRIGR Therapeutics |
| Sector | Life Science |
| Buyer(s) | Compass Therapeutics |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2014 |
| Sector | Life Science |
| Employees | 35 |
Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabs™ and common light-chain-based multispecific platforms to empirically identify multispecific and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. Compass Therapeutics was incorporated in 2014 and is based in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |